Joanna Jasińska

682 total citations
28 papers, 425 citations indexed

About

Joanna Jasińska is a scholar working on Immunology, Strategy and Management and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joanna Jasińska has authored 28 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Strategy and Management and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joanna Jasińska's work include Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Management Systems and Quality Improvement (6 papers). Joanna Jasińska is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Management Systems and Quality Improvement (6 papers). Joanna Jasińska collaborates with scholars based in Austria, Poland and United States. Joanna Jasińska's co-authors include Ursula Wiedermann, Michael Kundi, Christoph Zielinski, Hubert Pehamberger, Otto Scheiner, Erika Garner‐Spitzer, Heimo Breiteneder, Angelika Wagner, Herwig Kollaritsch and Stephan N. Wagner and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Joanna Jasińska

23 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Jasińska Austria 11 212 156 133 87 85 28 425
Philip Hobson United Kingdom 9 160 0.8× 124 0.8× 81 0.6× 47 0.5× 46 0.5× 13 365
Leclerc Claude France 9 279 1.3× 191 1.2× 113 0.8× 47 0.5× 52 0.6× 11 496
Matt Ardito United States 10 197 0.9× 259 1.7× 117 0.9× 77 0.9× 32 0.4× 11 437
M. Kronenberg United States 7 315 1.5× 332 2.1× 132 1.0× 52 0.6× 30 0.4× 9 585
Zakaria Benlasfar Tunisia 8 184 0.9× 251 1.6× 195 1.5× 56 0.6× 16 0.2× 15 463
Matthias Zehner Germany 11 241 1.1× 159 1.0× 53 0.4× 141 1.6× 42 0.5× 15 453
Sarah Baik United States 8 330 1.6× 155 1.0× 69 0.5× 124 1.4× 80 0.9× 8 524
Gunnel Engström Sweden 12 249 1.2× 236 1.5× 75 0.6× 62 0.7× 44 0.5× 16 497
Detlef Stober Germany 9 440 2.1× 123 0.8× 43 0.3× 49 0.6× 78 0.9× 9 563
Maiko Taneichi Japan 14 307 1.4× 237 1.5× 58 0.4× 85 1.0× 25 0.3× 31 467

Countries citing papers authored by Joanna Jasińska

Since Specialization
Citations

This map shows the geographic impact of Joanna Jasińska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Jasińska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Jasińska more than expected).

Fields of papers citing papers by Joanna Jasińska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Jasińska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Jasińska. The network helps show where Joanna Jasińska may publish in the future.

Co-authorship network of co-authors of Joanna Jasińska

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Jasińska. A scholar is included among the top collaborators of Joanna Jasińska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Jasińska. Joanna Jasińska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jasińska, Joanna. (2022). Patient safety in nursing care. 5(6). 1–5. 1 indexed citations
3.
Richter, Lukas, Daniela Schmid, Elisabeth Eva Kanitz, et al.. (2019). Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program. PLoS ONE. 14(1). e0210081–e0210081. 30 indexed citations
4.
Wagner, Angelika, Erika Garner‐Spitzer, Joanna Jasińska, et al.. (2018). Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules. Scientific Reports. 8(1). 9825–9825. 73 indexed citations
5.
Jasińska, Joanna. (2017). Problematyka doskonalenia procesu certyfikacji AQAP w resorcie obrony narodowej. Problemy Jakości. 1(8). 26–31. 1 indexed citations
6.
Tobias, Joshua, Joanna Jasińska, Karin Baier, et al.. (2017). Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer. 17(1). 118–118. 29 indexed citations
7.
Jasińska, Joanna. (2016). Metoda Bow-Tie w zastosowaniu do oceny ryzyka. 112–120.
8.
Jasińska, Joanna, et al.. (2015). Zapewnienie jakości żywności w dostawach dla wojska w świetle wymagań AQAP. 43. 234–243.
9.
Świderski, Andrzej, et al.. (2015). SELECTED ASPECTS OF MODELLING ESTIMATING RISK IN PROVIDING LOGISTICS SERVICES. 42(1). 191–202. 1 indexed citations
10.
Jasińska, Joanna & Andrzej Świderski. (2014). Modelowanie neuronowe w zastosowaniu do oceny zarządzania ryzykiem w logistyce. Gospodarka Materiałowa i Logistyka. 264–277.
11.
Jasińska, Joanna, et al.. (2013). Zarządzanie ryzykiem w pracach rozwojowych - zagrożenia a może szanse. Problemy Jakości. 45(4). 6–9. 1 indexed citations
12.
Hufnagl, Karin, Irma Schabussová, Joanna Jasińska, et al.. (2012). Prevention of Birch Pollen-Related Food Allergy by Mucosal Treatment with Multi-Allergen-Chimers in Mice. PLoS ONE. 7(6). e39409–e39409. 9 indexed citations
13.
Paulke‐Korinek, Maria, Gustav Fischmeister, Pamela Rendi‐Wagner, et al.. (2011). Persistence of antibodies in 4–8 year old Austrian children after vaccination with hexavalent DTaP–HBV–IPV/Hib and MMR vaccines. Vaccine. 29(32). 5130–5136. 14 indexed citations
14.
Wiedermann, Ursula, C Wiltschke, Joanna Jasińska, et al.. (2009). A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study. Breast Cancer Research and Treatment. 119(3). 673–683. 78 indexed citations
15.
Jasińska, Joanna & Andrzej Świderski. (2008). Metodyka oceny ryzyka w zapewnieniu jakości systemów logistycznych. Prace Naukowe Politechniki Warszawskiej. Transport. 59–66. 2 indexed citations
16.
Wiedermann, Ursula, Rinaldo Zurbriggen, Katarzyna Elandt, et al.. (2008). A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 3055–3055. 1 indexed citations
17.
Wagner, Stephan N., Joanna Jasińska, Heimo Breiteneder, et al.. (2007). Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice. Breast Cancer Research and Treatment. 106(1). 29–38. 21 indexed citations
18.
Jasińska, Joanna & Andrzej Świderski. (2006). Problemy oceny ryzyka w procesach realizacji wyrobów w aspekcie wymagań AQAP. Problemy Jakości. 18–20. 3 indexed citations
19.
Häfner, Christine, Stephan N. Wagner, Joanna Jasińska, et al.. (2005). Epitope-Specific Antibody Response to Mel-CAM Induced by Mimotope Immunization. Journal of Investigative Dermatology. 124(1). 125–131. 11 indexed citations
20.
Jasińska, Joanna, Stephan N. Wagner, Christian Radauer, et al.. (2003). Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her‐2/neu. International Journal of Cancer. 107(6). 976–983. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026